Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barnum

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Parkinson'S Disease|July 26, 2014
Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian ratsChristopher J Barnum, Xi Chen, Jaegwon Chung, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2011
Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned ratDavid Lindenbach, Corinne Y Ostock, Karen L Eskow Jaunarajs, et al.
Journal of the American Chemical Society|November 29, 2018
Synthetic and Spectroscopic Investigations Enabled by Modular Synthesis of Molecular Phosphaalkyne PrecursorsWesley J Transue, Junyu Yang, Matthew Nava, et al.
Journal of Neuroscience Research|December 31, 2008
Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian ratsChristopher Bishop, David M Krolewski, Karen L Eskow, et al.
Magnetic Resonance Imaging|August 3, 2014
Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approachXiangchuan Chen, Daniel E Huddleston, Jason Langley, et al.
Pharmacology, Biochemistry, and Behavior|October 8, 2011
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian ratsChristopher J Barnum, Nirmal Bhide, David Lindenbach, et al.
Alzheimer'S Research & Therapy|January 2, 2020
Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer's disease associated with obesity, metabolic syndrome, and type 2 diabetesMaria Elizabeth De Sousa Rodrigues, Madelyn C Houser, Douglas I Walker, et al.
Behavioural Brain Research|September 10, 2014
Two weeks of predatory stress induces anxiety-like behavior with co-morbid depressive-like behavior in adult male miceJillybeth Burgado, Constance S Harrell, Darrell Eacret, et al.
Journal of Inorganic Biochemistry|September 27, 2024
Synthesis, characterization and comparative biological activity of a novel set of Cu(II) complexes containing azole-based ligand framesCourtney E Elwell, Emily Stein, Adam Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2006
Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agentsPaul S Humphries, Jonathon V Almaden, Sandra J Barnum, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Parkinson'S Disease|July 26, 2014
Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian ratsChristopher J Barnum, Xi Chen, Jaegwon Chung, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2011
Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned ratDavid Lindenbach, Corinne Y Ostock, Karen L Eskow Jaunarajs, et al.
Journal of the American Chemical Society|November 29, 2018
Synthetic and Spectroscopic Investigations Enabled by Modular Synthesis of Molecular Phosphaalkyne PrecursorsWesley J Transue, Junyu Yang, Matthew Nava, et al.
Journal of Neuroscience Research|December 31, 2008
Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian ratsChristopher Bishop, David M Krolewski, Karen L Eskow, et al.
Magnetic Resonance Imaging|August 3, 2014
Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approachXiangchuan Chen, Daniel E Huddleston, Jason Langley, et al.
Pharmacology, Biochemistry, and Behavior|October 8, 2011
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian ratsChristopher J Barnum, Nirmal Bhide, David Lindenbach, et al.
Alzheimer'S Research & Therapy|January 2, 2020
Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer's disease associated with obesity, metabolic syndrome, and type 2 diabetesMaria Elizabeth De Sousa Rodrigues, Madelyn C Houser, Douglas I Walker, et al.
Behavioural Brain Research|September 10, 2014
Two weeks of predatory stress induces anxiety-like behavior with co-morbid depressive-like behavior in adult male miceJillybeth Burgado, Constance S Harrell, Darrell Eacret, et al.
Journal of Inorganic Biochemistry|September 27, 2024
Synthesis, characterization and comparative biological activity of a novel set of Cu(II) complexes containing azole-based ligand framesCourtney E Elwell, Emily Stein, Adam Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2006
Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agentsPaul S Humphries, Jonathon V Almaden, Sandra J Barnum, et al.
Pageof 7